Deutsche Bank Ag\ Vascular Biogenics Ltd. Transaction History

Deutsche Bank Ag\

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$0.96 - $1.57 $6,634 - $10,850	-6,911 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.1 - $1.32 $13,971 - $16,765	-12,701 Reduced 64.76%	6,911 $8,000
Q3 2019 Nov 14, 2019	SELL	$1.11 - $1.42 $16,969 - $21,708	-15,288 Reduced 43.81%	19,612 $26,000
Q2 2019 Aug 14, 2019	BUY	$1.16 - $1.53 $24,244 - $31,977	20,900 Added 149.29%	34,900 $45,000
Q1 2019 May 15, 2019	BUY	$0.94 - $1.75 $13,160 - $24,500	14,000 New	14,000 $21,000
Q4 2018 Feb 14, 2019	SELL	$0.6 - $1.72 $19,992 - $57,310	-33,320 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$1.55 - $2.17 $51,646 - $72,304	33,320 New	33,320 $54,000
Q1 2018 May 15, 2018	SELL	$2.27 - $8.5 $908 - $3,400	-400 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$5.65 - $9.0 $2,260 - $3,600	400	400 $2,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.